Surgery Partners Inc
$ 14.34
-1.98%
24 Apr - close price
- Market Cap 1,875,645,000 USD
- Current Price $ 14.34
- High / Low $ 14.67 / 13.89
- Stock P/E N/A
- Book Value 13.37
- EPS -0.61
- Next Earning Report 2026-05-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.03 %
- 52 Week High 24.18
- 52 Week Low 11.41
About
Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company is headquartered in Brentwood, Tennessee.
Analyst Target Price
$18.68
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-02 | 2025-11-10 | 2025-08-05 | 2025-05-05 | 2025-02-24 | 2024-11-12 | 2024-08-06 | 2024-05-07 | 2024-02-26 | 2023-11-07 | 2023-08-01 | 2023-05-01 |
| Reported EPS | 0.12 | 0.13 | -0.02 | 0.04 | 0.44 | -0.2512 | 0.21 | 0.1 | 0.44 | 0.19 | 0.28 | 0.08 |
| Estimated EPS | 0.3038 | 0.21 | 0.16 | 0.07 | 0.3769 | 0.25 | 0.2 | 0.07 | 0.38 | 0.16 | 0.08 | 0.01 |
| Surprise | -0.1838 | -0.08 | -0.18 | -0.03 | 0.0631 | -0.5012 | 0.01 | 0.03 | 0.06 | 0.03 | 0.2 | 0.07 |
| Surprise Percentage | -60.5003% | -38.0952% | -112.5% | -42.8571% | 16.7418% | -200.48% | 5% | 42.8571% | 15.7895% | 18.75% | 250% | 700% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.17 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SGRY
2026-04-24 02:39:52
Surgery Partners (SGRY) recently cut its earnings guidance due to slower surgical case growth, a less favorable payer mix, and reimbursement pressures. Despite these operational challenges, the company is focusing on higher-acuity procedures and robotics investments to reshape its case mix. This guidance cut challenges the near-term earnings recovery narrative and highlights the risk of weaker cash generation impacting growth funding and debt management.
2026-04-23 19:39:14
This article announces an ARS SEC filing by Surgery Partners, Inc. (SGRY) filed on April 23, 2026. The filing is an ARS type, indicating a specific regulatory disclosure, and is available as a PDF document on SEC EDGAR. The article also provides an overview of SGRY's stock performance, recent news, and other SEC filings.
2026-04-23 19:39:14
Surgery Partners (NASDAQ: SGRY) has detailed its 2026 virtual annual meeting scheduled for June 5, 2026, where stockholders will vote on the election of three Class II directors, an advisory say-on-pay resolution, and the ratification of Ernst & Young LLP as its independent auditor. The company reported 2025 revenue of $3.31 billion, a 6.2% increase, and Adjusted EBITDA of $526.2 million, up 3.5%, but experienced a net loss of $77.9 million, leading to no annual cash bonuses for named executive officers. The Board unanimously recommends voting "FOR" all management proposals, and stockholders can participate and vote online or via proxy.
2026-04-23 01:08:59
Surgery Partners (NASDAQ:SGRY) saw its stock price fall below its 200-day moving average to $14.58. The company missed Q4 earnings expectations, reporting wider losses per share than anticipated, though revenue slightly exceeded forecasts. Despite a "Moderate Buy" consensus from analysts and a $200 million stock buyback authorization, insider selling indicates some caution.
2026-04-23 00:39:14
This article compares Auna S.A. (AUNA) and Surgery Partners (SGRY), two healthcare service providers that generate revenue from hospital networks. Auna, with operations in Mexico, Peru, and Colombia, focuses on high-complexity diseases and shows strong regional performance and financial flexibility. Surgery Partners, concentrating on non-emergency surgical procedures, experienced a challenging fourth quarter in 2025 due to delayed capital deployment and unfavorable payer mix, leading to a weaker price performance and premium valuation compared to Auna.
2026-04-21 08:39:06
Allstate has filed a lawsuit against Surgery Partners, Inc. and several Florida-based surgery centers, alleging a multimillion-dollar billing scheme for exaggerated or unperformed medical procedures. The insurer claims the defendants billed for medically unnecessary or fabricated services following automobile accidents, impacting Personal Injury Protection payouts. Allstate named the parent company, Surgery Partners, Inc., as a defendant and is seeking triple damages under federal racketeering laws.
